Merck & Co., Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2025: USD 20.88 B

Merck & Co., Inc. Operating Cash Flow is USD 20.88 B for the Trailing 12 Months (TTM) ending March 31, 2025, a 41.48% change year over year. Operating cash flow is cash generated from the company’s regular business operations.
  • Merck & Co., Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2024 was USD 14.76 B, a -5.84% change year over year.
  • Merck & Co., Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2023 was USD 15.67 B, a -8.23% change year over year.
  • Merck & Co., Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2022 was USD 17.08 B, a 50.65% change year over year.
  • Merck & Co., Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2021 was USD 11.34 B, a -11.51% change year over year.
Key Data
Date Operating Cash Flow Capital Expenditure Net Cash Used For Investing Activities Net Cash Used Provided By Financing Activities